Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 1, 2012, Pages 96-101

  Ivanova, Radka ^a   Puerta, Susana ^a   Garrido, Alfonso ^a   Cueto, Ignacio ^b   Ferro, Ana ^a   Ariza, María José ^d   Cobos, Andrés ^c   González Santos, Pedro ^a   Valdivielso, Pedro ^a  

^a Division of Internal Medicine   (Spain)

^b Division of Gastroenterology   (Spain)

^c Division of Gastroenterologyand Laboratory   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Acute pancreatitis; Alcohol; Apolipoprotein E; Biliary lithiasis; Hypertriglyceridemia

Indexed keywords

APOLIPOPROTEIN E; TRIACYLGLYCEROL;

ACUTE PANCREATITIS; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; DYSLIPIDEMIA; GENE FREQUENCY; GENOTYPE; HOSPITALIZATION; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; PROGNOSIS; QUESTIONNAIRE; RECURRENT DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84855798575     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60131-8     Document Type: Article

References (45)

1. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008;371:143-152.
2. O'Farrell A, Allwright S, Toomey D, Bedford D, Conlon K. Hospital admission for acute pancreatitis in the Irish population, 1997 2004: could the increase be due to an increase in alcohol-related pancreatitis? J Public Health (Oxf) 2007;29:398-404.
3. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990;19:783-791.
4. Searles GE, Ooi TC. Underrecognition of chylomicronemia as a cause of acute pancreatitis. CMAJ 1992;147:1806-1808.
5. Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995;90:2134-2139.
6. Tsuang W, Navaneethan U, Ruiz L, Palascak JB, Gelrud A. Hypertriglyceridemic pancreatitis: presentation and management. Am J Gastroenterol 2009;104:984-991.
7. Brunzell JD, Bierman EL. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med Clin North Am 1982;66:455-468.
8. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992;37:249-273.
9. Wang J, Ban MR, Zou GY, Cao H, Lin T, Kennedy BA, et al. Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet 2008;17:2894-2899.
10. Brunzell JD, Deeb SS. Familial Lipoprotein Lipase deficiency, apo C-II deficiency and hepatic lipase deficiency. In: Scriver CR, Beaudet BL, Sly WS, Valle D, editors. The Metabolic & Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001:2789.
11. Calandra S, Priore Oliva C, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 2006;17:122-127.
12. Priore Oliva C, Pisciotta L, Li Volti G, Sambataro MP, Cantafora A, Bellocchio A, et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2005;25:411-417.
13. Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 2009;29:956-962.
14. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-537.
15. Coca-Prieto I, Valdivielso P, Olivecrona G, Ariza MJ, Rioja J, Font-Ugalde P, et al. Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis. BMC Gastroenterol 2009; 9:46.
16. Coca-Prieto I, Kroupa O, Gonzalez-Santos P, Magne J, Olivecrona G, Ehrenborg E, et al. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. J Intern Med 2011;270:224-228.
17. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-638.
18. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336.
19. Chatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J Clin Gastroenterol 2003;36:253-260.
20. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
21. Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 2009;10:49-52.
22. Kyriakidis AV, Karydakis P, Neofytou N, Pyrgioti M, Vasilakakis D, Digenis P, et al. Plasmapheresis in the management of acute severe hyperlipidemic pancreatitis: report of 5 cases. Pancreatology 2005;5:201-204.
23. Domínguez-Muñoz JE, Carballo F, García MJ, de Diego JM, Campos R, Yangüela J, et al. Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas 1993;8:682-686.
24. Mínguez M, García A, Boix V. Acute pancreatitis. A prospective epidemiological study in the province of Alicante. A Hospital Group for Study of Digestive Diseases in Alicante. Rev Esp Enferm Dig 1995;87:869-873.
25. Gonzálvez-Gasch A, de Casasola GG, Martín RB, Herreros B, Guijarro C. A simple prognostic score for risk assessment in patients with acute pancreatitis. Eur J Intern Med 2009;20: e43-48.
26. Winslet M, Hall C, London NJ, Neoptolemos JP. Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis. Gut 1992;33:982-986.
27. Navarro S, Cubiella J, Feu F, Zambón D, Fernández-Cruz L, Ros E. Hypertriglyceridemic acute pancreatitis. Is its clinical course different from lithiasic acute pancreatitis? Med Clin (Barc) 2004;123:567-570.
28. Chang CC, Hsieh YY, Tsai HD, Yang TC, Yeh LS, Hsu TY. Acute pancreatitis in pregnancy. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61:85-92.
29. Deng LH, Xue P, Xia Q, Yang XN, Wan MH. Effect of admission hypertriglyceridemia on the episodes of severe acute pancreatitis. World J Gastroenterol 2008;14:4558-4561.
30. Lloret Linares C, Pelletier AL, Czernichow S, Vergnaud AC, Bonnefont-Rousselot D, Levy P, et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008;37:13-22.
31. Klatskin G, Gordon M. Relationship between relapsing pancreatitis and essential hyperlipemia. Am J Med 1952;12:3-23.
32. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipemia. Evidence for a persistent defect in lipid metabolism. Am J Med 1974;56:482-487.
33. Cameron JL, Zuidema GD, Margolis S. A pathogenesis for alcoholic pancreatitis. Surgery 1975;77:754-763.
34. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 2000;106:773-781.
35. Hof bauer B, Friess H, Weber A, Baczako K, Kisling P, Schilling M, et al. Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 1996;38:753-758.
36. Wang Y, Sternfeld L, Yang F, Rodriguez JA, Ross C, Hayden MR, et al. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut 2009;58:422-430.
37. Criddle DN, Raraty MG, Neoptolemos JP, Tepikin AV, Petersen OH, Sutton R. Ethanol toxicity in pancreatic acinar cells: mediation by nonoxidative fatty acid metabolites. Proc Natl Acad Sci U S A 2004;101:10738-10743.
38. Grauvogel J, Daemmrich TD, Ryschich E, Gebhard MM, Werner J. Chronic alcohol intake increases the severity of pancreatitis induced by acute alcohol administration, hyperlipidemia and pancreatic duct obstruction in rats. Pancreatology 2010;10:603-612.
39. Ariza MJ, Sánchez-Chaparro MA, Barón FJ, Hornos AM, Calvo-Bonacho E, Rioja J, et al. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study. BMC Med Genet 2010;11:66.
40. Rollán A, Loyola G, Covarrubias C, Giancaspero R, Acevedo K, Nervi F. Apolipoprotein E polymorphism in patients with acute pancreatitis. Pancreas 1994;9:349-353.
41. Wen T, Liu L, Nie S. The relationship between apolipoprotein E genotype and hypertriglyceridemia-associated recurrent acute pancreatitis. Zhonghua Wai Ke Za Zhi 2008;46:1579-1582.
42. Ghiselli G, Schaefer EJ, Zech LA, Gregg RE, Brewer HB Jr. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest 1982;70:474-477.
43. Valdivielso P, Sánchez-Chaparro MA, Calvo-Bonacho E, Cabrera-Sierra M, Sainz-Gutiérrez JC, Fernández-Labandera C, et al. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis 2009;207:573-578.
44. Valdivielso P, Pintó X, Mateo-Gallego R, Masana L, Alvarez-Sala L, Jarauta E, et al. Clinical features of patients with hypertriglyceridemia referred to lipid units: registry of hypertrigliceridemia of the Spanish Arteriosclerosis Society. Med Clin (Barc) 2011;136:231-238.
45. Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003;332:11-19.